Doctor Leslie Marisol Lugo Gavidia
CONSAM, Santiago de Queretaro (Mexico)
Biography
Dr. Leslie Marisol Lugo Gavidia, MD, MSc. Graduate of Queretaro ́s Autonomous University; Mexico 2014 and certified as a medical doctor (M.D.) she continued her training on cardiovascular disease in the Queretaro´s Heart Institute (Mexico) and participated in national projects focusing on projects to improve coronary artery disease diagnosis, treatment and prognosis. She obtained her Master´s degree in biomedical sciences (2017) on which she focused platelet aggregation and CAD. Following this, she did a fellowship in Barcelona at the Bellvitge Biomedical Research Institute (IDIBELL) in the Bellvitge University Hospital focused on antithrombotic therapy and CAD and the impact to the long term outcome on this patients. Currently PhD student at The University of Western Australia in the Medical Research Foundation (MRF), Royal Perth Hospital (RPH) and Dobney Hypertension Centre (DHC).
Contributor content
Presentation
Impact of the type of acute coronary syndrome on the pharmocodynamic response to P2Y12 inhibitors in the acute and maintenance phase of therapy
Presentation
Impact of 2017 ACC/AHA new recommendation for blood pressure target goals on an hispanic population
Presentation
Underuse of prasugrel and ticagrelor in patients with chronic kidney disease despite achieving a more effective platelet inhibition than clopidogrel
Presentation
